GlassScriptPhysician profile
James K Roberts
NPI 1326115999
$2,063.99
in general payments reported to CMS, 2019-2025
16 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $70.28 · 2021: $154 · 2022: $468 · 2023: $212 · 2024: $273 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $535.60 | 2022-2025 | Botox, Ubrelvy |
| Allergan, INC. | $346.24 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $279.62 | 2022 | |
| Supernus Pharmaceuticals, INC. | $197.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $161.97 | 2019-2020 | |
| Pfizer INC. | $95.62 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $92.55 | 2019-2022 | |
| Emd Serono, INC. | $90.39 | 2019 | |
| Csl Behring | $72.04 | 2019 | |
| Tg Therapeutics, INC. | $69.55 | 2023-2024 | |
| Eisai INC. | $25.43 | 2025 | |
| Grifols USA, LLC | $23.52 | 2023 | Gamunex-C |
| Celgene Corporation | $21.55 | 2022 | |
| Lundbeck LLC | $19.38 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $16.67 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strongbridge US INC. | $16.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.